PAHC
Phibro Animal Health Corporation
NASDAQ: PAHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$52.50
-3.30% today
Updated 2026-04-29
Market cap
$2.13B
P/E ratio
23.23
P/S ratio
1.45x
EPS (TTM)
$2.26
Dividend yield
0.88%
52W range
$18 – $60
Volume
0.3M
Phibro Animal Health Corporation (PAHC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$52.50
12-Month target
$71.25
2030 Target
—
Intrinsic (DCF)
$128.61
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.8B | $0.9B | $1.0B | $1.0B | $1.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 23.23x (capped 25x) · Margin: 6.29%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.